← Back to Search

Furosemide for Acute Kidney Failure

N/A
Waitlist Available
Led By Jay L Koyner, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the index hospital stay, an average of 17 days, until hospital discharge, or until death, whatever occurs first
Awards & highlights

Study Summary

This trial is testing if new biomarkers can help predict the severity of acute kidney injury and improve patient outcomes.

Eligible Conditions
  • Acute Kidney Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the index hospital stay, an average of 17 days, until hospital discharge, or until death, whatever occurs first
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the index hospital stay, an average of 17 days, until hospital discharge, or until death, whatever occurs first for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Death
Progression to Stage 3 AKI
Receipt of Renal Replacement Therapy (RRT)
Secondary outcome measures
Length of Hospital Stay
Length of Intensive Care Unit (ICU) Stay

Trial Design

1Treatment groups
Experimental Treatment
Group I: LasixExperimental Treatment1 Intervention
Pt to get dose of furosemide after meeting entry criteria - dose dependent on previous exposure to diuretics
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Furosemide
FDA approved

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,003 Previous Clinical Trials
819,653 Total Patients Enrolled
Jay L Koyner, MDPrincipal InvestigatorUniversity of Chicago
3 Previous Clinical Trials
507 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025